公立资助、国家监管的区域医院服务中893个单基因病植入前遗传学诊断周期的十三年经验
该研究总结了蒙彼利埃区域医院中心在全额报销服务框架下开展单基因病植入前遗传学诊断(PGD)的经验。在法国限制性法律框架下,仅可检测胚胎中的亲源遗传风险(不允许同时进行非整倍体筛查)。基于PCR技术结合突变检测与基因内或侧翼紧密连锁短串联重复标记,建立了针对61种单基因病的100余种荧光多重检测方法,用于卵裂期胚胎卵裂球分析。共384对夫妇启动893个周期,727个周期进行取卵,608个周期进行胚胎移植,获得184次分娩。
要点
- 共启动893个PGD周期,384对夫妇,727个周期取卵,608个周期移植,184次分娩。
- 每移植周期临床妊娠率33.6%,植入率25.1%,流产率8.8%。
- 358对夫妇中162对(45.3%)获得214名健康婴儿。
核心结论
- 在不允许非整倍体筛查但在地域和社会经济层面提供平等PGD机会的组织框架内,该PGD项目使358对夫妇中的162对(45.3%)获得214名健康婴儿,构成一项相关成就。
- 这是全额免费PGD服务的罕见例子。
研究设计与样本
- 在蒙彼利埃区域医院中心全额报销服务背景下,对384对夫妇启动的893个单基因病PGD周期进行概述。
- 在法国限制性法律框架下,仅可研究胚胎中的亲源遗传风险,不允许同时进行非整倍体筛查。
主要发现
- 共384对夫妇启动893个周期,727个周期进行取卵,608个周期进行胚胎移植,获得184次分娩。
- 每移植周期临床妊娠率为33.6%,植入率为25.1%,流产率为8.8%。
- 358对夫妇中162对(45.3%)获得214名健康婴儿。
关键数值与推荐
- 基于PCR技术结合突变检测与基因内或侧翼紧密连锁短串联重复标记,建立针对61种单基因病的100余种稳健荧光多重检测方法。
- 该策略用于分析卵裂期胚胎的卵裂球。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
This study provides an overview of preimplantation genetic diagnosis (PGD) for single gene diseases and the management of expanding indications in the context of a fully financially covered service at Montpellier's regional hospital centre. Within the framework of a restrictive law ruling PGD in France, only the parental genetic risk can be studied in embryos (concurrent aneuploidy screening is not allowed). PCR-based techniques were developed combining mutation detection and closely linked short tandem repeat markers within or flanking the affected genes, and set up more than 100 different robust fluorescent multiplex assays for 61 monogenic disorders. This strategy was used to analyse blastomeres from cleavage-stage embryos. Overall, 893 cycles were initiated in 384 couples; 727 cycles proceeded to oocyte retrieval and 608 cycles to embryo transfer, resulting in 184 deliveries. Clinical pregnancy rate per transfer, implantation and miscarriage rates were 33.6%, 25.1% and 8.8%, respectively. Our PGD programme resulted in the birth of 214 healthy babies for 162 out of 358 couples (45.3%), constituting a relevant achievement within an organizational framework that does not allow aneuploidy screening but provides equal access to PGD, both geographically and socioeconomically. This is a rare example of a fully free-of-charge PGD service.
引用
- Girardet A, Ishmukhametova A, Viart V, et al. Thirteen years' experience of 893 PGD cycles for monogenic disorders in a publicly funded, nationally regulated regional hospital service. Reprod Biomed Online. 2017. PMID: 29203382. doi:10.1016/j.rbmo.2017.10.113
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。